Conoscere EBM
- Definizione
- Acronimi
- Cronologia
- Ambiti
- Know-how e strumenti
- EBM in 4 step
- Limiti e ostacoli

EB Practice
- Formulazione quesito
- Ricerca evidenze
- Valutazione evidenze
- Applicazione evidenze

EBHC Library
- Risorse in italiano

SSN Hot Topics
- Appropriatezza
- Conflitti di interesse
- ECM
- Farmaci
- Governo Clinico
- LEA

InfoSanità

Workshop Clinici Interattivi

Introduzione	Osteoporosi	Adenoma ipofisario	Ipertiroidismo

---

• Slides

• Slides
• Evidence appraised
• Linee guida
• AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. American Association of Clinical Endocrinologists/American College of Endocrinology. 1996 Mar-Apr
• Record NGC
• Osteoporosis. American Health Care Association/American Medical Directors Association. 1998
• Physician's guide to prevention and treatment of osteoporosis. 1999
• Osteoporosis prevention, diagnosis, and therapy. Office of Medical Applications of Research. 2000 Mar 27-29
• Record NGC
• Clinical practice guidelines for the diagnosis and management of osteoporosis, 15 Oct 1996, Osteoporosis Society of Canada
• The Canadian Consensus Conference on Menopause and Osteoporosis, Nov-Dec 1998, Society of Obstetricians and Gynaecologists of Canada
• Writing Group for the Royal College of Physicians and the Bone and Tooth Society of Great Britain. Osteoporosis: Clinical guidelines for Prevention and Treatment. Update on Pharmacological Interventions and an Algorithm for Management. London: Royal College of Physicians, 2000.
• Update 2001
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
• Technology assessment
• Espallargues M, Dolors Estrada M, Sola M, Sampietro-Colom L, del Rio L, Granados A.Guidelines for the indication of bone densitometry in the assessment of fracture risk. Catalan Agency for Health Technology Assessment (CAHTA) 1999:19
• Revisioni sistematiche
• Cochrane
• D Haguenauer, V Welch, B Shea, P Tugwell, G Wells. Fluoride for treating postmenopausal osteoporosis. In: The Cochrane Library, 2, 2001. Oxford: Update Software [abstract]
• Ricerca primaria (RCTs ed altri studi)
• Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R, Kitano S. Bone mineral density in patients taking H2-receptor antagonist.Calcif Tissue Int 1998;62:283-5 [abstract]
• Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA. 1999;282:637-45.Studio MORE [abstract]
• Commenti allo studio MORE
• ACP Journal Club
• Bollettino d'Informazione ai Farmaci 2000;4:35-37

• Slides
• Evidence appraised
• Linee guida
• Nessuna
• Revisioni sistematiche
• Nessuna
• Revisioni narrative
• Boscaro M, Barzon L, Fallo F. Cushing’s syndrome. Lancet 2001; 357: 783–91
• Boscaro M, Barzon L, Sonino N. The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings. Arch Intern Med 2000;160:3045-53.
• Pecori Giraldi F, Invitti C, Cavagnini F.Inferior petrosal sinus sampling ten years down the road. J Endocrinol Invest 2000;23:325-7.
• Kirk LF, Hash RB, Katner HP, Jones T. Cushing's disease: clinical manifestations and diagnostic evaluation. Am Fam Phys 2000;62:1119-27
• Newell-Price J, Trainer P, Besser M, Grossman A.The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states Endocr Rev 1998;19:647-72
• Ricerca primaria (RCTs ed altri studi)
• Colao A, Faggiano A, Pivonello R, Giraldi FP, Cavagnini F, Lombardi G. Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study. Eur J Endocrinol 2001;144:499-507 [abstract]
• Bonelli FS, Huston J, Carpenter PC, Erickson D, Young WF, Meyer FB. Adrenocorticotropic hormone-dependent Cushing's syndrome: sensitivity and specificity of inferior petrosal sinus sampling. AJNR Am J Neuroradiol 2000 Apr;21(4):690-6
• Wiggam MI, Heaney AP, McIlrath EM, et al. Bilateral inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin dependent Cushing's syndrome: a comparison with other diagnostic tests.J Clin Endocrinol Metab 2000;85:1525-32

• Slides
• Evidence appraised
• Linee guida
• Nessuna
• Revisioni sistematiche
• Nessuna
• Revisioni narrative
• Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy. Endocrinol Metab Clin North Am 2000;29:297-319 [abstract]
• Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives.Endocr Rev 2000;21:168-99
• Rasmussen AK, Nygaard B, Feldt-Rasmussen U. (131)I and thyroid-associated ophthalmopathy.Eur J Endocrinol. 2000;143:155-60
• Ricerca primaria (RCTs ed altri studi)
• Mourits MP, van Kempen-Harteveld ML, Garcia MB, et al. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study. Lancet 2000;355:1505-9
• Kahaly GJ, Rosler HP, Pitz S, Hommel G. Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab 2000;85:102-8